论文部分内容阅读
在体内纤维蛋白肽链 A 和β-血栓球蛋白被作为凝血酶活性增强或血小板活化的标记。观察 ARF者以上指标明显增高。由于肾功能不全可干扰这些标记物质的清除,人们有必要问,这些标记物浓度的增加是否真正表明 ARF 时的高凝状态。为检验上述可能性,在32例 ARF 患者中,我们将纤维蛋白肽
In vivo fibrinopeptide A and beta-thromboglobulin are used as markers of increased thrombin activity or platelet activation. The above indicators of ARF were significantly higher. Because renal insufficiency can interfere with the clearance of these markers, it is necessary to ask if the increase in these markers really indicates hypercoagulability at ARF. To test the above-mentioned possibility, in 32 cases of ARF patients, we will fibrin peptide